Pharma Times -- Eli Lilly has paid $1.27 billion to become the founding private partner of a new partnership between the US and Russia designed to encourage collaboration on shared priorities in health related research.
Pharma Times -- Eli Lilly has paid $1.27 billion to become the founding private partner of a new partnership between the US and Russia designed to encourage collaboration on shared priorities in health related research.
